Evan Y. Yu
Active 2001–2026
- Also published as
- Evan Y Yu
- 152
- Papers
- 25,001
- Citations
- 61
- h-index
- 137
- i10-index
Citations
Citation sources
Countries
Institutions
Fields
- Medicine65.2%
- Biochemistry, Genetics and Molecular Biology28.9%
- Immunology and Microbiology2.9%
- Neuroscience0.7%
- Agricultural and Biological Sciences0.4%
- Engineering0.4%
- Other1.5%
Topics
- Prostate Cancer Treatment and Research11.4%
- Cancer Immunotherapy and Biomarkers5%
- Prostate Cancer Diagnosis and Treatment4.7%
- Bladder and Urothelial Cancer Treatments4.5%
- Extracellular vesicles in disease2.9%
- Cancer Genomics and Diagnostics2.4%
- Other69.1%
Coauthors
- Bruce Montgomery31
- Heather H. Cheng27
- Michael T. Schweizer26
- Peter S. Nelson23
- Daniel P. Petrylak20
- Petros Grivas20
- Roman Gulati16
- Andrea Necchi15
- Jonathan E. Rosenberg15
- Maurice P. Zeegers14
- Neeraj Agarwal14
- Thomas Powles14
- Anke Wesselius13
- Jonathan L. Wright13
- Matthew D. Galsky13
- Emmanuel S. Antonarakis12
- Johann S. de Bono12
- Srikala S. Sridhar12
- Alexandra Drakaki11
- Colin C. Pritchard11
- Margitta Retz11
- Mary‐Ellen Taplin11
- Michael C. Haffner11
- Todd Yezefski11
All papers
- Integrative Clinical Genomics of Advanced Prostate Cancer
Authors: Dan R. Robinson, Eliezer M. Van Allen, Yi-Mi Wu, Nikolaus Schultz, Robert J. Lonigro, Juan Miguel Mosquera, Bruce Montgomery, Mary-Ellen Taplin, Colin C. Pritchard, Gerhardt Attard, Himisha Beltran, Wassim Abida, Robert K. Bradley, Jake Vinson, Xuhong Cao, Pankaj Vats, Lakshmi P. Kunju, Maha Hussain, Felix Y. Feng, Scott A. Tomlins, Kathleen A. Cooney, David C. Smith, Christine Brennan, Javed Siddiqui, Rohit Mehra, Yu Chen, Dana E. Rathkopf, Michael J. Morris, Stephen B. Solomon, Jeremy C. Durack, Victor E. Reuter, Anuradha Gopalan, Jianjiong Gao, Massimo Loda, Rosina T. Lis, Michaela Bowden, Stephen Balk, Glenn C. Gaviola, Carrie Sougnez, Manaswi Gupta, Evan Y. Yu, Elahe A. Mostaghel, Heather H. Cheng, Hyojeong Mulcahy, Lawrence D. True, Stephen R. Plymate, Heidi Dvinge, Roberta Ferraldeschi, Penny Flohr, Susana Miranda, Zafeiris Zafeiriou, Nina Tunariu, Joaquı́n Mateo, Raquel Pérez-López, Francesca Demichelis, Brian D. Robinson, Marc Schiffman, David M. Nanus, Scott T. Tagawa, Alexandros Sigaras, Kenneth Eng, Olivier Elemento, Andrea Sboner, Elisabeth I. Heath, Howard I. Scher, Kenneth J. Pienta, Philip W. Kantoff, Johann S. de Bono, Mark A. Rubin, Peter S. Nelson, Levi A. Garraway, Charles L. Sawyers, Arul M. Chinnaiyan - Cell 2015 cited by 3,701
- Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial
Authors: Arjun Vasant Balar, Matthew D. Galsky, Jonathan E. Rosenberg, Thomas Powles, Daniel P. Petrylak, Joaquim Bellmunt, Yohann Loriot, Andrea Necchi, Jean Hoffman‐Censits, José Luis Perez‐Gracia, Nancy A. Dawson, Michiel S. van der Heijden, Robert Dreicer, Sandy Srinivas, Margitta Retz, Richard W. Joseph, Alexandra Drakaki, Ulka N. Vaishampayan, Srikala S. Sridhar, David I. Quinn, Ignacio Durán, David R. Shaffer, Bernhard J. Eigl, Petros Grivas, Evan Y. Yu, Shi Li, Edward E. Kadel, Zachary Boyd, Richard Bourgon, Priti S. Hegde, Sanjeev Mariathasan, AnnChristine Thåström, Oyewale O. Abidoye, Gregg Fine, Dean F. Bajorin - The Lancet 2016 cited by 2,211
- Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial
Authors: Thomas Powles, Tibor Csőszi, Mustafa Özgüroğlu, Nobuaki Matsubara, Lajos Géczi, Susanna Cheng, Yves Fradet, Stéphane Oudard, Christof Vulsteke, Rafael Morales‐Barrera, Aude Fléchon, Şeyda Gündüz, Yohann Loriot, Alejo Rodríguez‐Vida, Ronac Mamtani, Evan Y. Yu, Kijoeng Nam, Kentaro Imai, Blanca Homet Moreno, Ajjai Alva, D. Cascallar, Mirta Varela, Mauricio Fernández Lazzaro, Diego Kaen, Gabriela Gatica, David Hugo Flores, Agustín Falco, Matias Molina, F. Van Aelst, Christof Vulsteke, Brieuc Sautois, Jean‐Pascal Machiels, Denis Schallier, Leandro Brust, Liane Rapatoni, Sérgio Jobim Azevedo, GISELE LOPES MARINHO, João Paulo Holanda Soares, Carlos Dzik, Jamile Almeida Silva, André P. Fay, Joel Gingerich, Yves Fradet, Cristiano Ferrario, Kylea Potvin, Marie Vanhuyse, Mahmoud Abdelsalam, Susanna Cheng, Christian Caglevic, Felipe Reyes, José Luis Leal, Francisco Francisco, Carolina Ibáñez, Florence Joly, Brigitte Laguerre, Sylvain Ladoire, Aude Fléchon, Delphine Topart, Olivier Huillard, Stéphane Oudard, Marine Gross‐Goupil, Stéphane Culine, Yohann Loriot, Gwénaëlle Gravis, Peter Reichardt, Margitta Retz, Jan Herden, David G. Pfister, Carsten Ohlman, Michael Stöeckle, Manfred P. Wirth, Anja Lorch, Guenter Niegisch, Peter J. Goebell, Martin Boegemann, Axel S. Merseburger, Georgios Gakis, Jens Bedke, Andreas Neisius, Christian A. Thomas, Thomas Hoefner, András Telekes, Judit Kósa, János Révész, Gyorgy Bodoky, Tibor Csőszi, András Csejtei, Lajos Géczi, Ágnes Ruzsa, Zsuzsanna Kolonics, József Erfán, Ray McDermott, Richard Bambury, Avishay Sella, Stephen Jay Frank, Daniel Kejzman, Olesya Goldman, Eli Rosenbaum, Avivit Peer, Raanan Berger and 158 more - The Lancet Oncology 2021 cited by 648
- Lentivirus-delivered stable gene silencing by RNAi in primary cells
Authors: Sheila A. Stewart, Derek M. Dykxhoorn, Deborah Palliser, Hana Mizuno, Evan Y. Yu, Dong Sung An, David M. Sabatini, Irvin S. Y. Chen, William C. Hahn, Phillip A. Sharp, Robert A. Weinberg, Carl D. Novina - RNA 2003 cited by 1,646
- Pivotal Trial of Enfortumab Vedotin in Urothelial Carcinoma After Platinum and Anti-Programmed Death 1/Programmed Death Ligand 1 Therapy
Authors: Jonathan E. Rosenberg, Peter H. O’Donnell, Arjun Vasant Balar, Bradley A. McGregor, Elisabeth I. Heath, Evan Y. Yu, Matthew D. Galsky, Noah M. Hahn, Elaina M. Gartner, Juan Pinelli, Shang-Ying Liang, Amal Melhem‐Bertrandt, Daniel P. Petrylak - Journal of Clinical Oncology 2019 cited by 626
- Quantitative and stoichiometric analysis of the microRNA content of exosomes
Authors: John R. Chevillet, Qing Kang, Ingrid K. Ruf, Hilary Briggs, Lucia Vojtech, Sean M. Hughes, Heather H. Cheng, Jason D. Arroyo, Emily Meredith, Emily N. Gallichotte, Era L. Pogosova‐Agadjanyan, Colm Morrissey, Derek L. Stirewalt, Florian Hladik, Evan Y. Yu, Celestia S. Higano, Muneesh Tewari - National Academy of Sciences, Proceedings of the National Academy of Sciences 2014 cited by 1,095
- Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
Authors: Charles J. Ryan, Matthew R. Smith, Johann S. de Bono, Arturo Molina, Christopher J. Logothetis, Paul de Souza, Karim Fizazi, Paul N. Mainwaring, Josep M. Piulats, Siobhan Ng, Joan Carles, Peter F.A. Mulders, Ethan Basch, Eric J. Small, Fred Saad, Dirk Schrijvers, Hendrik Van Poppel, Som D. Mukherjee, H. Suttmann, Winald R. Gerritsen, Thomas W. Flaig, Daniel J. George, Evan Y. Yu, Eleni Efstathiou, Allan J. Pantuck, Eric Winquist, Celestia S. Higano, Mary-Ellen Taplin, Youn Park, Thian Kheoh, Thomas W. Griffin, Howard I. Scher, Dana E. Rathkopf - New England Journal of Medicine 2012 cited by 2,795
- Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer
Authors: Mark P. Labrecque, Ilsa M. Coleman, Lisha G. Brown, Lawrence D. True, Lori Kollath, Bryce Lakely, Holly M. Nguyen, Yu Chi Yang, Rui M. Gil da Costa, Arja Kaipainen, Roger Coleman, Celestia S. Higano, Evan Y. Yu, Heather H. Cheng, Elahe A. Mostaghel, Bruce Montgomery, Michael T. Schweizer, Andrew C. Hsieh, Daniel W. Lin, Eva Corey, Peter S. Nelson, Colm Morrissey - Journal of Clinical Investigation 2019 cited by 468
- The Role of Lineage Plasticity in Prostate Cancer Therapy Resistance
Authors: Himisha Beltran, Andrew M. Hruszkewycz, Howard I. Scher, Jeffrey Hildesheim, Jennifer S. Isaacs, Evan Y. Yu, Kathleen Kelly, Daniel W. Lin, Adam P. Dicker, Julia T. Arnold, Toby T. Hecht, Max S. Wicha, Rosalie C. Sears, David R. Rowley, Richard M. White, James L. Gulley, John K. Lee, Maria Diaz Meco, Eric J. Small, Michael M. Shen, Karen E. Knudsen, David W. Goodrich, Tamara L. Lotan, Amina Zoubeidi, Charles L. Sawyers, Charles M. Rudin, Massimo Loda, Timothy C. Thompson, Mark A. Rubin, Abdul Tawab-Amiri, William L. Dahut, Peter S. Nelson - Clinical Cancer Research 2019 cited by 394
- Enfortumab vedotin after PD-1 or PD-L1 inhibitors in cisplatin-ineligible patients with advanced urothelial carcinoma (EV‑201): a multicentre, single-arm, phase 2 trial
Authors: Evan Y. Yu, Daniel P. Petrylak, Peter H. O’Donnell, Jae‐Lyun Lee, Michiel S. van der Heijden, Yohann Loriot, Mark N. Stein, Andrea Necchi, Takahiro Kojima, Michael R. Harrison, Se Hoon Park, David I. Quinn, Elisabeth I. Heath, Jonathan E. Rosenberg, Joyce Steinberg, Shang-Ying Liang, Janet Trowbridge, Mary S. Campbell, Bradley A. McGregor, Arjun Vasant Balar - The Lancet Oncology 2021 cited by 267
- Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer
Authors: Akash Kumar, Ilsa M. Coleman, Colm Morrissey, Xiaotun Zhang, Lawrence D. True, Roman Gulati, Ruth Etzioni, Hamid Bolouri, Bruce Montgomery, Thomas A. White, Jared M. Lucas, Lisha G. Brown, Ruth F. Dumpit, Navonil De Sarkar, Celestia S. Higano, Evan Y. Yu, Roger Coleman, Nikolaus Schultz, Min Fang, Paul H. Lange, Jay Shendure, Robert L. Vessella, Peter S. Nelson - Nature Medicine 2016 cited by 763
- Pembrolizumab Plus Olaparib for Patients With Previously Treated and Biomarker-Unselected Metastatic Castration-Resistant Prostate Cancer: The Randomized, Open-Label, Phase III KEYLYNK-010 Trial
Authors: Emmanuel S. Antonarakis, Se Hoon Park, Jeffrey C. Goh, Sang Joon Shin, Jae‐Lyun Lee, Niven Mehra, Ray McDermott, Núria Sala‐González, Peter C.C. Fong, Richard Greil, Margitta Retz, Juan Pablo Sade, Patricio Yañez, Eric Yi‐Hsiu Huang, Stephen Begbie, Rustem Gafanov, Maria De Santis, Eli Rosenbaum, Michael Kolinsky, Felipe Rey, Kun‐Yuan Chiu, Guilhem Roubaud, Gero Kramer, Makoto Sumitomo, Francesco Massari, Hiroyoshi Suzuki, Ping Qiu, Jinchun Zhang, Jeri Kim, Christian Poehlein, Evan Y. Yu - Journal of Clinical Oncology 2023 cited by 132
- Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial
Authors: Matthew R Smith, Matthew R Smith, Howard I Scher, Shahneen Sandhu, Eleni Efstathiou, Primo N Lara, Evan Y Yu, Daniel J George, Kim N Chi, Fred Saad, Olof Ståhl, David Olmos, Daniel C Danila, Gary E Mason, Byron M Espina, Xin Zhao, Karen A Urtishak, Peter Francis, Angela Lopez-Gitlitz, Karim Fizazi, Francis Parnis, Anthony M. Joshua, Lisa G. Horvath, Christopher Steer, Gavin Marx, Shahneen Sandhu, Howard Gurney, Thomas Ferguson, Siska Van Bruwaene, Daisy Luyten, Peter Schatteman, Nicolaas Lumen, Luc Dirix, Jean-Charles Goeminne, Thierry Gil, Emmanuel Seront, Christof Vulsteke, Celio Kussumoto, Fabio A. Franke, Fabricio Augusto Martinelli de Oliveira, Andrea Juliana Pereira de Santana Gomes, Hélio Pinczowski, Daniel D'Almeida Preto, Luis Eduardo Zucca, Giuliano Santos Borges, Andre M. Murad, Fred Saad, Kim N. Chi, Yves Fradet, Neil E. Fleshner, Urban Emmenegger, Klaus Brasso, Karim Fizazi, Stephane Culine, Antoine Thiery-Vuillemin, Florence Joly, Aude Fléchon, Werner Hilgers, Jean-Christophe Eymard, Delphine Borchiellini, Philippe Barthélémy, Raanan Berger, Raya Leibowitz-Amit, Wilmosh Mermershtain, Keren Rouvinov, Avivit Peer, Svetlana Kovel, Avishay Sella, Martijn P. Lolkema, Alfonsus J.M. van den Eertwegh, Johannes Voortman, Maureen J. Aarts, Jourik A. Gietema, Choung-Soo Kim, Young-Deuk Choi, Byung-Ha Chung, Rustem A. Gafanov, Evgeniy Kopyltsov, Evgeny A. Usynin, Joan Carles, Begoña Mellado, José Pablo Maroto, Jesús García-Donás, Juan Francisco Rodríguez Moreno, Ignacio Durán, Begoña Pérez-Valderrama, Elena Castro, David Olmos, María José Méndez-Vidal, David Lorente Estellés, Regina Gironés Sarrió, José Muñoz-Langa, Urbano Anido Herranz, Javier Puente Vázquez, Enrique Castellanos, Martin Hellström, Anders Widmark, Ingela Franck Lissbrant, Åsa Jellvert, Cecilia Külich and 34 more - The Lancet Oncology 2022 cited by 186
- Tucatinib and Trastuzumab for Previously Treated Human Epidermal Growth Factor Receptor 2–Positive Metastatic Biliary Tract Cancer (SGNTUC-019): A Phase II Basket Study
Authors: Yoshiaki Nakamura, Nobumasa Mizuno, Yu Sunakawa, Jean-Luc Canon, Matthew D. Galsky, Erika Hamilton, Hidetoshi Hayashi, Guy Jérusalem, Seung Tae Kim, Keun‐Wook Lee, Lionel Aurelien Kankeu Fonkoua, Bradley J. Monk, Danny Nguyen, Do‐Youn Oh, Alicia Okines, David M. O’Malley, Paula R. Pohlmann, Martin Reck, Sang Joon Shin, Kazuki Sudo, Shunji Takahashi, Cédric van Marcke, Evan Y. Yu, Roman Groisberg, Jorge Ramos, Sherry Tan, Thomas E. Stinchcombe, Tanios Bekaii‐Saab - Journal of Clinical Oncology 2023 cited by 100
- Association of Clonal Hematopoiesis in DNA Repair Genes With Prostate Cancer Plasma Cell-free DNA Testing Interference
Authors: Kendal Jensen, Eric Q. Konnick, Michael T. Schweizer, Alexandra Sokolova, Petros Grivas, Heather H. Cheng, Nola Klemfuss, Mallory Beightol, Evan Y. Yu, Peter S. Nelson, Bruce Montgomery, Colin C. Pritchard - JAMA Oncology 2020 cited by 158
- Integrative Clinical Genomics of Advanced Prostate Cancer
Authors: Dan R. Robinson, Eliezer M. Van Allen, Yi‐Mi Wu, Nikolaus Schultz, Robert J. Lonigro, Juan‐Miguel Mosquera, Bruce Montgomery, Mary‐Ellen Taplin, Colin C. Pritchard, Gerhardt Attard, Himisha Beltran, Wassim Abida, Robert K. Bradley, Jake Vinson, Xuhong Cao, Pankaj Vats, Lakshmi P. Kunju, Maha Hussain, Felix Y. Feng, Scott A. Tomlins, Kathleen A. Cooney, David C. Smith, Christine Brennan, Javed Siddiqui, Rohit Mehra, Yu Chen, Dana E. Rathkopf, Michael J. Morris, Stephen B. Solomon, Jeremy C. Durack, Victor E. Reuter, Anuradha Gopalan, Jianjiong Gao, Massimo Loda, Rosina T. Lis, Michaela Bowden, Stephen Balk, Glenn C. Gaviola, Carrie Sougnez, Manaswi Gupta, Evan Y. Yu, Elahe A. Mostaghel, Heather H. Cheng, Hyojeong Mulcahy, Lawrence D. True, Stephen R. Plymate, Heidi Dvinge, Roberta Ferraldeschi, Penny Flohr, Susana Miranda, Zafeiris Zafeiriou, Nina Tunariu, Joaquı́n Mateo, Raquel Pérez-López, Francesca Demichelis, Brian D. Robinson, Andrea Sboner, Marc Schiffman, David M. Nanus, Scott T. Tagawa, Alexandros Sigaras, Kenneth Eng, Olivier Elemento, Andrea Sboner, Elisabeth I. Heath, Howard I. Scher, Kenneth J. Pienta, Philip W. Kantoff, Johann S. de Bono, Mark A. Rubin, Peter S. Nelson, Levi A. Garraway, Charles L. Sawyers, Arul M. Chinnaiyan - Cell 2015 cited by 591
- Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019
Authors: Veda N. Giri, Karen E. Knudsen, William Kevin Kelly, Heather H. Cheng, Kathleen A. Cooney, Michael S. Cookson, William L. Dahut, Scott M. Weissman, Howard R. Soule, Daniel P. Petrylak, Adam P. Dicker, Saud H. AlDubayan, Amanda E. Toland, Colin C. Pritchard, Curtis A. Pettaway, Mary B. Daly, James L. Mohler, J. Kellogg Parsons, Peter R. Carroll, Robert Pilarski, Amie Blanco, Ashley Woodson, Alanna Kulchak Rahm, Mary-Ellen Taplin, Thomas J. Polascik, Brian T. Helfand, Colette Hyatt, Alicia K. Morgans, Felix Y. Feng, Michael P. Mullane, Jacqueline Powers, Raoul S. Concepcion, Daniel W. Lin, Richard C. Wender, James Ryan Mark, Anthony J. Costello, Arthur L. Burnett, Oliver Sartor, William B. Isaacs, Jianfeng Xu, Jeffrey N. Weitzel, Gerald L. Andriole, Himisha Beltran, Alberto Briganti, Lindsey Byrne, Anne Calvaresi, Thenappan Chandrasekar, David Y.T. Chen, Robert B. Den, Albert Dobi, E. David Crawford, James A. Eastham, Scott E. Eggener, Matthew L. Freedman, Marc B. Garnick, Patrick T. Gomella, Nathan Handley, Mark Hurwitz, Joseph K. Izes, R. Jeffrey Karnes, Costas D. Lallas, Lucia R. Languino, Stacy Loeb, Ana María López, Kevin R. Loughlin, Grace Lu‐Yao, S. Bruce Malkowicz, Mark Mann, Patrick Mille, Martin Miner, Todd M. Morgan, José Moreno, Lorelei A. Mucci, Ronald E. Myers, Sarah M. Nielsen, Brock O’Neil, Wayne H. Pinover, Peter A. Pinto, Wendy Poage, Ganesh V. Raj, Timothy R. Rebbeck, Charles J. Ryan, Howard M. Sandler, Matthew J. Schiewer, Emily Scott, Brittany M. Szymaniak, William Tester, Edouard J. Trabulsi, Neha Vapiwala, Evan Y. Yu, Charnita Zeigler‐Johnson, Leonard G. Gomella - Journal of Clinical Oncology 2020 cited by 279
- Primary analysis from DS8201-A-U105: A phase 1b, two-part, open-label study of trastuzumab deruxtecan (T-DXd) with nivolumab (nivo) in patients (pts) with HER2-expressing urothelial carcinoma (UC).
Authors: Matt D. Galsky, Gianluca Del Conte, Silvia Foti, Evan Y. Yu, Jean‐Pascal Machiels, Bernard Doger, Andrea Necchi, Filippo de Braud, Erika Hamilton, Audrey Hennequin, Tom Van den Mooter, Philip R. Debruyne, Irene Moreno, Hendrik‐Tobias Arkenau, Zenta Tsuchihashi, Fu-Chih Cheng, Bincy Augustine, Ben Cheng, Daniel Barrios, Diana Lüftner - Journal of Clinical Oncology 2022 cited by 85
- Pembrolizumab Plus Docetaxel and Prednisone in Patients with Metastatic Castration-resistant Prostate Cancer: Long-term Results from the Phase 1b/2 KEYNOTE-365 Cohort B Study
Authors: Evan Y. Yu, Michael Kolinsky, William L. Berry, Margitta Retz, Loı̈c Mourey, Josep M. Piulats, Leonard J. Appleman, Emanuela Romano, Gwénaëlle Gravis, Howard Gurney, Martin Bögemann, Urban Emmenegger, Anthony M. Joshua, Mark Linch, Srikala S. Sridhar, Henry Jacob Conter, Brigitte Laguerre, Christophe Massard, Xin Tong Li, Charles Schloss, Christian Poehlein, Johann S. de Bono - European Urology 2022 cited by 79
- IL-7 expands lymphocyte populations and enhances immune responses to sipuleucel-T in patients with metastatic castration-resistant prostate cancer (mCRPC)
Authors: Russell K. Pachynski, Chihiro Morishima, Russell Z. Szmulewitz, Lauren C. Harshman, Leonard J. Appleman, Paul Monk, Rhonda L. Bitting, Ömer Küçük, Frederick Millard, John D. Seigne, Steven P. Fling, Holden T. Maecker, Caroline Duault, Nirasha Ramchurren, Bruce W. Hess, Leonard D’Amico, Andreanne M. Lacroix, Judith C. Kaiser, Michel Morre, Anne Grégoire, Martin A. Cheever, Evan Y. Yu, Lawrence Fong - Journal for ImmunoTherapy of Cancer 2021 cited by 67
- Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1–2 study
Authors: Howard I. Scher, Tomasz M. Beer, Celestia S. Higano, Aseem Anand, Mary‐Ellen Taplin, Eleni Efstathiou, Dana E. Rathkopf, Julia Shelkey, Evan Y. Yu, Joshi J. Alumkal, David T. Hung, Mohammad Hirmand, Lynn Seely, Michael J. Morris, Daniel C. Danila, John L. Humm, Steven M. Larson, Martin Fleisher, Charles L. Sawyers - The Lancet 2010 cited by 1,084
- Disparities in Cancer Care and the Asian American Population
Authors: Richard J. Lee, Ravi A. Madan, Jayoung Kim, Edwin M. Posadas, Evan Y. Yu - The Oncologist 2021 cited by 141
- A phase I study of niclosamide in combination with enzalutamide in men with castration-resistant prostate cancer
Authors: Michael T. Schweizer, Kathleen Haugk, Jožefa S. McKiernan, Roman Gulati, Heather H. Cheng, Jessica L. Maes, Ruth F. Dumpit, Peter S. Nelson, Bruce Montgomery, Jeannine S. McCune, Stephen R. Plymate, Evan Y. Yu - PLoS ONE 2018 cited by 137
- Genome-wide genotype-serum proteome mapping provides insights into the cross-ancestry differences in cardiometabolic disease susceptibility
Authors: Fengzhe Xu, Evan Y. Yu, Xue Cai, Liang Yue, Lipeng Jing, Xinxiu Liang, Yuanqing Fu, Zelei Miao, Min Yang, Menglei Shuai, Wanglong Gou, Congmei Xiao, Zhangzhi Xue, Yuting Xie, Sainan Li, Sha Lu, Meiqi Shi, Xuhong Wang, Wensheng Hu, Claudia Langenberg, Jian Yang, Yu‐Ming Chen, Tiannan Guo, Ju‐Sheng Zheng - Nature Communications 2023 cited by 60
